Drospirenone-containing oral contraceptive pills and the risk of venous thromboembolism: a systematic review of observational studies.

The effects of fourth-generation drospirenone-containing combined oral contraceptives (COCs) on the risk of venous thromboembolism (VTE) are controversial.